PATHALYS PHARMA
Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.
PATHALYS PHARMA
Industry:
Biopharma Biotechnology
Founded:
2021-01-01
Address:
Raleigh, North Carolina, United States
Country:
United States
Website Url:
http://www.pathalys.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
11 M USD
Current Advisors List
Current Employees Featured
Founder
Investors List
DaVita Venture Group
DaVita Venture Group investment in Seed Round - Pathalys Pharma
Catalys Pacific
Catalys Pacific investment in Seed Round - Pathalys Pharma
Official Site Inspections
http://www.pathalys.com
- Host name: 150.31.127.34.bc.googleusercontent.com
- IP address: 34.127.31.150
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Pathalys Pharma"
Pathalys Pharma - Crunchbase Company Profile
Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease. Pathalys' initial focus will be on …See details»
Pathalys Pharma - LinkedIn
Pathalys Pharma is a private, late-stage clinical biopharmaceutical company committed to the development of advanced therapeutics that address unmet needs in the management of late-stage chronic ...See details»
Pathalys Pharma Raises $150 Million in Secured …
Jan 18, 2023 Pathalys’ initial asset is upacicalcet, a novel calcimimetic with the potential to improve the treatment of SHPT in hemodialysis patients. Beyond upacicalcet, Pathalys continues to identify other high priority needs and …See details»
Pathalys Pharma, Inc. Launches with Mission to Address High …
Mar 1, 2022 Pathalys launches with a novel clinical-stage asset, upacicalcet, that was acquired through a license granted by EA Pharma for exclusive rights to the development and …See details»
Pathalys Pharma Org Chart + Executive Team - The Official Board
Organizational Chart of Pathalys Pharma. Pathalys Pharma Org Chart pathalys.com. has 10 executives +1 251 8555; Add an executive. Pathalys Pharma News . Anything missing? We …See details»
Pathalys Pharma, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Pathalys Pharma, Inc. of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
Pathalys Pharma Company Profile - Office Locations, Competitors …
Pathalys Pharma is a clinical biopharmaceutical company that provides therapeutics development solutions. It offers treatment for patients with end-stage chronic kidney disease (CKD). The …See details»
Pathalys Pharma, Inc. - VentureRadar
Pathalys Pharma, Inc. is a private, late-stage clinical biopharmaceutical company committed to the development of multiple advanced therapeutics that address unmet needs in the …See details»
Pathalys Pharma - Funding, Financials, Valuation & Investors
Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease. New. Resources. Advanced Search. ... How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead InvestorsSee details»
Pathalys Pharma - Contacts, Employees, Board Members
Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease. ... Experience the new Crunchbase, powered by AI . Experience …See details»
Pathalys Pharma Appoints Leadership Team, Led by …
Mar 31, 2022 Pathalys Pharma, a newly formed biopharmaceutical company developing therapies for chronic kidney disease, has announced its executive leadership team, led by Neal Fowler, a veteran entrepreneur in North …See details»
Pathalys Pharma Announces Executive Team Appointments
Mar 30, 2022 RESEARCH TRIANGLE PARK, N.C., March 30, 2022 – Pathalys Pharma, Inc., a private, late-stage biopharma company committed to the development and commercialization …See details»
Pathalys Pharma - Portfolio Company Profile, Executives and …
See Pathalys Pharma's complete profile, including its private equity owner and the number of its executive contacts in our database. Pathalys Pharma is a late-stage clinical biopharmaceutical …See details»
Pathalys Pharma, Inc. Launches with Mission to ... - Catalys Pacific
Mar 1, 2022 Pathalys launches with a novel clinical-stage asset, upacicalcet, that was acquired through a license granted by EA Pharma for exclusive rights to the development and …See details»
Pathalys Pharma Inc. | North Carolina Biotech Center
Pathalys Pharma Inc. Pathalys Pharma Inc. Pathalys Pharma develops therapeutics that address unmet needs in the management of end stage kidney disesase (ESKD). Company Location. …See details»
Pathalys Pharma Announces Executive Team Appointments
Mar 30, 2022 Pathalys officially launched on March 1, 2022. "It is my privilege to announce Pathalys' executive team. This robust and highly capable team of leaders has extensive …See details»
Pathalys - 2025 Company Profile, Funding & Competitors - Tracxn
Feb 27, 2025 Pathalys - Provider of CKD biotherapeutics development services. Raised a total funding of $105M over 2 rounds from 11 investors. Founded by Ashwin Ram, BT Slingsby and …See details»
Pathalys Pharma, Inc. Launches with Mission to Address High …
Mar 1, 2022 Pathalys launches with a novel clinical-stage asset, upacicalcet, ... I am very optimistic about the future of our organization and our lead asset, upacicalcet, as well as the …See details»
Pathalys raises $105M to advance kidney disease treatment
Aug 23, 2024 In summary, Pathalys Pharma's recent series B funding marks a significant milestone in the company's journey to advance its kidney disease therapy. With strong …See details»